Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Centerpulse strength helps Zimmer beat Q4 guidance

This article was originally published in Clinica

Executive Summary

Announcing its first set of revenues incorporating those of Swiss orthopaedics and reconstructive surgery group Centerpulse, Zimmer yesterday said that its sales for the fourth quarter of 2003 are likely to come in at $700m, beating Wall Street's First Call projections ($666m) by 10%. EPS (before acquisition costs, write-offs and inventory step-up) is expected to outperform consensus guidance of $0.44 by 11% at least.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057082

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel